DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary

International Journal of Gynecological Cancer

Volumn 3, Issue 6, 1993, Pages 349-358

  Kaern, J ^a   Tropie C G ^a   Kristensen, G B ^a   Abeler, V M ^a   Pettersen, E O ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Borderline tumors; DNA ploidy; Flow cytometry; Ovary; Prognostic factors

Indexed keywords

ANEUPLOIDY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RISK; CANCER SURVIVAL; CORRELATION FUNCTION; DIPLOIDY; DNA POLYMORPHISM; FEMALE; FLOW CYTOMETRY; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; OVARY TUMOR;

EID: 0027424597     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1993.03060349.x     Document Type: Article

References (33)

1. Bostwick DG, Tazelaar HD, Ballon SC, Hendrickson MR, Kempson RL. Ovarian epithelial tumors of borderline malignancy: a clinical and pathologic study of 109 cases. Cancer 1986; 58: 2052-65.
2. Fox H. Prognostic indices in ovarian mours of borderline malignancy with particular reference to morphometric analysis. In: Sharp F, Soutter WP, eds. Ovarian Cancer: The Way Ahead. London: Royal College of obstetricians and gynecologists, 1987; 69-78.
3. Russell P. The pathological assessments of ovarian neoplasms II. The prolifering epithelial tumours. Pathology 1979; 11: 259-82.
4. Fox H. Ovarian tumors of borderline malignancy. Recent Clinical Developments in Gynecologic Oncology 1979; 24: 137-50.
5. Baak JPA, Fox H, Langley FA, Buckley CH. The prognostic value of morphometry in ovarian epithelial tumours of borderline malignancy. Int J Gynecol Path 1985; 4: 186-91.
6. Friedlander ML, Taylor IW, Russell P, Musgrove EA, Hedley DW, Tattersall MHN. Ploidy as a prognostic factor in ovarian cancer. Int J Gynecol Path 1983; 2: 55-63.
7. Rodenburg CJ, Cornelisse CJ, Heintz PAM, Hermans J, Fleuren GJ. Tumor ploidy as a major prognostic factor in advanced ovarian cancer. Cancer 1987; 59: 317-23.
8. Weiss RR, Richart RM, Okagaki T. DNA content of mucinous tumors of the ovary. Am J Obstet Gynecol 1969; 107: 409-24.
9. Friedlander ML, Russell P, Taylor IW, Hedley DW, Tattersall MHN. Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy. Pathology 1984; 16: 301-6.
10. Erhardt K, Auer G, Bj6rkholm E, et al. Prognostic significance of nuclear DNA content in serous ovarian tumors. Cancer Res 1984; 44: 2198-202.
11. Dietel M, Arps H, Rohlff A, Bodecker R, Niendorf A. Nuclear DNA content of borderline tumors of the ovary: correlation with histology and significance for prognosis. Virchows Arch (Pathol Anat) 1986; 409: 829-36.
12. Fu YS, Ro J, Reagan JW, Hall TL, Berek J. Nuclear deoxyribonucleic acid heterogeneity of ovarian borderline malignant serous tumors. Obstet Gynecol 1986; 67: 478-82.
13. Kühn W, Kaufmann M, Feichter GE, Rummel HH, Schmid H, Heberling D. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors. Gynecol Oncol 1987; 33: 360-7.
14. Iversen OE, Skaarland E. Ploidy assessement of benign and malignant ovarian tumors by flow cytometry: a clinicopathologic study. Cancer 1987; 60: 82-7.
15. Klemi PJ, Joensuu H, Kilholma P, Maenp/ia J. Clinical significance of abnormal nuclear DNA content in serous ovarian tumors. Cancer 1988; 62: 2005-10.
16. Olinici CD, Caluser I. DNA nuclear content in borderline ovarian tumors. Morphol-Embryol 1988; 24: 49-52.
17. Kaern J, Trope C, Kjørstad KE, Abeler V, Pettersen EO. Cellular DNA content as a new prognostic tool in patients with boderline tumors of the ovary. Gynecol Oncol 1990; 38: 452-7.
18. Andersen ES, Nielsen K, Nielsen RH. Borderline epithelial tumours of the ovary. Abstract IGGS, International Gynecologic Cancer Society, Third Biennial Meeting 22-26 Sept. 1991, Cairns. Australia.
19. Ingelrnan-Sundberg A. Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scand 1971; 50: 1-7.
20. Hart WR, Norris HJ. Borderline and malignant mucinous tumors of the ovary. Cancer 1973; 31: 1031-45.
21. Scully RE. Tumors of the ovary and maldeveloped gonads. In: Atlas of Tumor Pathology. Sec. series. Fasc. 16. Washington: Armed Forces Institute of pathology 1979.
22. Serow SF, Scully RE, Sobin LH. International histological classification of tumours No 9: Histologic Typing of Ovarian Tumours. World Health Organization 1973.
23. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin embedded patholgical material using flow cytometry. J Histochem Cytochem 1983; 31: 1333-5.
24. Fossd SD, Shoaib MC, Pettersen EO, Thorud E. DNA flow cytometry of cells obtained from old paraffin embedded specimens. A comparison with results of scanning absorption cytometry. Pathol Res Pract 1984; 181: 200-5.
25. Foss SD, Thorud E, Shoaib MC, Pettersen EO, Hoie J, Scott- Knudsen O. DNA flow cytornetry in primary breast carcinoma. Acta Pathol Microbiol Immunol Scand Sect 1986; 92: 475-80.
26. Lindmo T, Steen HB. Characteristics of a simple high resolution flow cytometry based on a flow configuration. Biophys J 1979; 28:33-44.
27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
28. Tarone RE, Ware J. On distribution-free tests for equality of survival distributions. Biometrika 1977; 64: 156-60.
29. Cox DR. Regression models and life tables. J R Soc Ser B 1972; 34: 187-220.
30. Kaern J, Trope CG, Abeler V. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital 1970-1982. A review of clinico-pathological features and treatment modalities. Cancer 1993; 71: 1810-20.
31. Tazelaar HD, Bostwick DG, Ballon SC, Hendrickson MR, Kempson RL. Conservative treatment of borderline ovarian tumours. Obstet Gynecol 1985; 66: 417-22.
32. Piura B, Dganis R, Blicksteins I, Yanai-Inbar I, Czernobilsky B, Glezerman M. Epithelial ovarian tumors of borderline malignancy: a study of 50 cases. Int J Gynecol Cancer 1992; 2: 189-97.
33. Kaern J, Wetteland J, Trope CG, et al. Comparison between flow cytometry and image cytometry in ploidy distribution assessments in gynecologic cancer. Cytomet 1992; 13:314-21.